D
Mesoblast Limited
MEOBF
$1.37
-$0.25-15.43%
D
Sell
3/19/2025Upgraded
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 3/19/2025 due to an increase in the total return index and valuation index.
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 3/19/2025 due to an increase in the total return index and valuation index.
E
Sell
2/26/2025Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 2/26/2025 due to a decline in the valuation index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 2/26/2025 due to a decline in the valuation index.
D
Sell
2/3/2025Upgraded
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 2/3/2025 due to a major increase in the total return index, volatility index and growth index.
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 2/3/2025 due to a major increase in the total return index, volatility index and growth index.
E
Sell
1/7/2025Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 1/7/2025 due to a decline in the valuation index and solvency index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 1/7/2025 due to a decline in the valuation index and solvency index.
D
Sell
4/17/2024Upgraded
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 4/17/2024 due to an increase in the solvency index and volatility index.
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 4/17/2024 due to an increase in the solvency index and volatility index.
E
Sell
8/7/2023Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 8/7/2023 due to a decline in the total return index, volatility index and growth index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 8/7/2023 due to a decline in the total return index, volatility index and growth index.
D
Sell
7/21/2023Upgraded
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 7/21/2023 due to an increase in the total return index and volatility index.
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 7/21/2023 due to an increase in the total return index and volatility index.
E
Sell
7/6/2023Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 7/6/2023 due to a decline in the volatility index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 7/6/2023 due to a decline in the volatility index.
D
Sell
6/21/2023Upgraded
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 6/21/2023 due to an increase in the growth index, total return index and volatility index. EBIT increased 27.5% from -$19.83M to -$14.38M, earnings per share increased from -$0.0332 to -$0.0253, and operating cash flow increased 1.24% from -$16.45M to -$16.25M.
Mesoblast Limited (MEOBF) was upgraded to D- from E+ on 6/21/2023 due to an increase in the growth index, total return index and volatility index. EBIT increased 27.5% from -$19.83M to -$14.38M, earnings per share increased from -$0.0332 to -$0.0253, and operating cash flow increased 1.24% from -$16.45M to -$16.25M.
E
Sell
3/14/2023Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/28/2023Downgrade
Mesoblast Limited (MEOBF) was downgraded to D- from D on 2/28/2023 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0243 to -$0.0332, the quick ratio declined from 1.82 to 1.31, and EBIT declined 23.89% from -$16.01M to -$19.83M.
Mesoblast Limited (MEOBF) was downgraded to D- from D on 2/28/2023 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0243 to -$0.0332, the quick ratio declined from 1.82 to 1.31, and EBIT declined 23.89% from -$16.01M to -$19.83M.
D
Sell
2/9/2023Upgraded
Mesoblast Limited (MEOBF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Mesoblast Limited (MEOBF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index, solvency index and volatility index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index, solvency index and volatility index.
D
Sell
5/16/2022Upgraded
Mesoblast Limited (MEOBF) was upgraded to D from E+ on 05/16/2022.
Mesoblast Limited (MEOBF) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Mesoblast Limited (MEOBF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
Mesoblast Limited (MEOBF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
E
Sell
4/20/2022Downgrade
Mesoblast Limited (MEOBF) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and solvency index.
Mesoblast Limited (MEOBF) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, volatility index and solvency index.
D
Sell
11/23/2021Upgraded
Mesoblast Limited (MEOBF) was upgraded to D from D- on 11/23/2021 due to an increase in the volatility index.
Mesoblast Limited (MEOBF) was upgraded to D from D- on 11/23/2021 due to an increase in the volatility index.
D
Sell
11/8/2021Downgrade
Mesoblast Limited (MEOBF) was downgraded to D- from D on 11/8/2021 due to a large decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.63 to 1.48, and debt to equity increased from 0.16 to 0.17.
Mesoblast Limited (MEOBF) was downgraded to D- from D on 11/8/2021 due to a large decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.63 to 1.48, and debt to equity increased from 0.16 to 0.17.
D
Sell
3/24/2021Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 3/24/2021 due to a major decline in the total return index, growth index and volatility index. Operating cash flow declined 13.47% from -$28.17M to -$31.96M, and earnings per share declined from -$0.0421 to -$0.0438.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 3/24/2021 due to a major decline in the total return index, growth index and volatility index. Operating cash flow declined 13.47% from -$28.17M to -$31.96M, and earnings per share declined from -$0.0421 to -$0.0438.
D
Sell
10/16/2020Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 10/16/2020 due to an increase in the valuation index and volatility index.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 10/16/2020 due to an increase in the valuation index and volatility index.
D
Sell
10/1/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 10/1/2020 due to a decline in the valuation index.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 10/1/2020 due to a decline in the valuation index.
D
Sell
9/9/2020Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 9/9/2020 due to an increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.81 to 1.44, and debt to equity declined from 0.18 to 0.17.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 9/9/2020 due to an increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.81 to 1.44, and debt to equity declined from 0.18 to 0.17.
D
Sell
8/25/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 8/25/2020 due to a decline in the valuation index.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 8/25/2020 due to a decline in the valuation index.
D
Sell
5/29/2020Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 5/29/2020 due to a significant increase in the growth index. Total revenue increased 453.08% from $2.21M to $12.2M, earnings per share increased from -$0.046 to -$0.0284, and EBIT increased 33.73% from -$23.42M to -$15.52M.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 5/29/2020 due to a significant increase in the growth index. Total revenue increased 453.08% from $2.21M to $12.2M, earnings per share increased from -$0.046 to -$0.0284, and EBIT increased 33.73% from -$23.42M to -$15.52M.
D
Sell
5/22/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 5/22/2020 due to a decline in the total return index and growth index.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 5/22/2020 due to a decline in the total return index and growth index.
D
Sell
5/11/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 5/11/2020 due to a major decline in the efficiency index, total return index and valuation index.
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 5/11/2020 due to a major decline in the efficiency index, total return index and valuation index.
C
Hold
4/24/2020Upgraded
Mesoblast Limited (MEOBF) was upgraded to C- from D on 4/24/2020 due to a substantial increase in the total return index.
Mesoblast Limited (MEOBF) was upgraded to C- from D on 4/24/2020 due to a substantial increase in the total return index.
D
Sell
4/23/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 4/23/2020 due to a noticeable decline in the total return index and volatility index.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 4/23/2020 due to a noticeable decline in the total return index and volatility index.
D
Sell
4/8/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 4/8/2020 due to a noticeable decline in the total return index and valuation index.
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 4/8/2020 due to a noticeable decline in the total return index and valuation index.
C
Hold
3/17/2020Upgraded
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 3/17/2020 due to a noticeable increase in the total return index and valuation index.
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 3/17/2020 due to a noticeable increase in the total return index and valuation index.
D
Sell
2/28/2020Downgrade
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 2/28/2020 due to a noticeable decline in the total return index, growth index and solvency index. EBIT declined 496.36% from -$3.9M to -$23.28M, earnings per share declined from -$0.011 to -$0.046, and total revenue declined 87.06% from $17.05M to $2.21M.
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 2/28/2020 due to a noticeable decline in the total return index, growth index and solvency index. EBIT declined 496.36% from -$3.9M to -$23.28M, earnings per share declined from -$0.011 to -$0.046, and total revenue declined 87.06% from $17.05M to $2.21M.
C
Hold
2/12/2020Upgraded
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 2/12/2020 due to a major increase in the total return index and volatility index.
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 2/12/2020 due to a major increase in the total return index and volatility index.
D
Sell
12/23/2019Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 12/23/2019 due to an increase in the total return index and volatility index.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 12/23/2019 due to an increase in the total return index and volatility index.
D
Sell
11/29/2019Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 11/29/2019 due to a decline in the growth index, solvency index and volatility index. The quick ratio declined from 1.21 to 0.74, and debt to equity increased from 0.17 to 0.18.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 11/29/2019 due to a decline in the growth index, solvency index and volatility index. The quick ratio declined from 1.21 to 0.74, and debt to equity increased from 0.17 to 0.18.
D
Sell
11/25/2019Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 11/25/2019 due to a noticeable increase in the total return index, volatility index and valuation index.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 11/25/2019 due to a noticeable increase in the total return index, volatility index and valuation index.
D
Sell
2/4/2019Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 2/4/2019 due to a noticeable decline in the total return index and volatility index.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 2/4/2019 due to a noticeable decline in the total return index and volatility index.
D
Sell
12/4/2018Downgrade
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 12/4/2018 due to a decline in the volatility index and total return index.
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 12/4/2018 due to a decline in the volatility index and total return index.
C
Hold
11/19/2018Upgraded
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 11/19/2018 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 584.53% from $1.7M to $11.64M, EBIT increased 26.39% from -$22.8M to -$16.78M, and earnings per share increased from -$0.044 to -$0.0407.
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 11/19/2018 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 584.53% from $1.7M to $11.64M, EBIT increased 26.39% from -$22.8M to -$16.78M, and earnings per share increased from -$0.044 to -$0.0407.
D
Sell
10/4/2018Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 10/4/2018 due to an increase in the volatility index and total return index.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 10/4/2018 due to an increase in the volatility index and total return index.
D
Sell
9/19/2018Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 9/19/2018 due to a decline in the volatility index.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 9/19/2018 due to a decline in the volatility index.
D
Sell
9/4/2018Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 9/4/2018 due to a significant increase in the growth index, efficiency index and solvency index. Total revenue increased 58.88% from $1.07M to $1.7M, the quick ratio increased from 2.85 to 3.64, and EBIT increased 3.41% from -$23.61M to -$22.8M.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 9/4/2018 due to a significant increase in the growth index, efficiency index and solvency index. Total revenue increased 58.88% from $1.07M to $1.7M, the quick ratio increased from 2.85 to 3.64, and EBIT increased 3.41% from -$23.61M to -$22.8M.
D
Sell
8/30/2017Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 8/30/2017 due to a significant decline in the growth index, solvency index and efficiency index. Net income declined 177.82% from -$9.78M to -$27.18M, earnings per share declined from -$0.0246 to -$0.064, and the quick ratio declined from 2.53 to 1.35.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 8/30/2017 due to a significant decline in the growth index, solvency index and efficiency index. Net income declined 177.82% from -$9.78M to -$27.18M, earnings per share declined from -$0.0246 to -$0.064, and the quick ratio declined from 2.53 to 1.35.
D
Sell
5/15/2017Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 5/15/2017 due to a large increase in the total return index, growth index and volatility index. Total revenue increased 39.24% from $395 to $550.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 5/15/2017 due to a large increase in the total return index, growth index and volatility index. Total revenue increased 39.24% from $395 to $550.
D
Sell
5/12/2016Upgraded
Mesoblast Limited (MEOBF) was upgraded to D from D- on 5/12/2016 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.3145 to -$0.2245, total revenue increased 3.19% from $4.01M to $4.14M, and EBIT increased 2.19% from -$20.83M to -$20.38M.
Mesoblast Limited (MEOBF) was upgraded to D from D- on 5/12/2016 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.3145 to -$0.2245, total revenue increased 3.19% from $4.01M to $4.14M, and EBIT increased 2.19% from -$20.83M to -$20.38M.
D
Sell
3/11/2016Downgrade
Mesoblast Limited (MEOBF) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and efficiency index.
Mesoblast Limited (MEOBF) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and efficiency index.
D
Sell
2/17/2016Downgrade
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 2/17/2016 due to a substantial decline in the growth index, efficiency index and volatility index. Total revenue declined 46.57% from $7.51M to $4.01M, and operating cash flow declined 29.43% from -$28.07M to -$19.81M.
Mesoblast Limited (MEOBF) was downgraded to D from D+ on 2/17/2016 due to a substantial decline in the growth index, efficiency index and volatility index. Total revenue declined 46.57% from $7.51M to $4.01M, and operating cash flow declined 29.43% from -$28.07M to -$19.81M.
D
Sell
1/15/2016Downgrade
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 1/15/2016 due to a large decline in the total return index.
Mesoblast Limited (MEOBF) was downgraded to D+ from C- on 1/15/2016 due to a large decline in the total return index.
C
Hold
12/31/2015Upgraded
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 12/31/2015 due to a large increase in the growth index and total return index.
Mesoblast Limited (MEOBF) was upgraded to C- from D+ on 12/31/2015 due to a large increase in the growth index and total return index.
D
Sell
12/28/2015Upgraded
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 12/28/2015 due to a noticeable increase in the growth index, total return index and efficiency index. Earnings per share increased from -$0.411 to -$19.7, total revenue increased 46.9% from $5.11M to $7.51M, and operating cash flow increased 10.68% from -$25.36M to -$28.07M.
Mesoblast Limited (MEOBF) was upgraded to D+ from D on 12/28/2015 due to a noticeable increase in the growth index, total return index and efficiency index. Earnings per share increased from -$0.411 to -$19.7, total revenue increased 46.9% from $5.11M to $7.51M, and operating cash flow increased 10.68% from -$25.36M to -$28.07M.
D
Sell
12/4/2015None
Mesoblast Limited (MEOBF) was downgraded to D from U on 12/04/2015.
Mesoblast Limited (MEOBF) was downgraded to D from U on 12/04/2015.
OTC PK
03/12/2025 3:45PM Eastern
Quotes delayed
